ANI Pharmaceuticals aims to surpass $1 billion in sales by 2026, with a significant focus on rare diseases. Cortrophin Gel, a lead asset, saw a 76% revenue increase in 2025, driving the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results